BBOTVSNUS• 28 Days (Normalized)
BBOT vs NUS (BridgeBio Oncology Therapeutics Inc. vs Nu Skin Enterprises Inc.)
Showing Closing Date Range from Sep 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.5
-60.5%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
NUS Performance $4.74
-0.21%
Nu Skin Enterprises Inc.
Normalized Baseline0.00%
Alpha Spread Margin NUS LEADS
-60.29 pts
NUS outperforming by 60.29 percentage points
BBOTNUS
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT NUS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BBOT Price | BBOT Gain (%) | NUS Price | NUS Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.50 | -60.50% | $4.74 | -0.21% | -60.29% |
| Oct 05, 2026 | $3.60 | -59.37% | $4.63 | -2.53% | -56.84% |
| Oct 02, 2026 | $3.89 | -56.09% | $4.61 | -2.95% | -53.14% |
| Sep 30, 2026 | $4.10 | -53.72% | $- | - | |
| Sep 29, 2026 | $3.92 | -55.76% | $- | - | |
| Sep 28, 2026 | $3.81 | -57.00% | $- | - | |
| Sep 25, 2026 | $3.95 | -55.42% | $- | - | |
| Sep 24, 2026 | $3.99 | -54.97% | $4.62 | -2.74% | -52.23% |
| Sep 23, 2026 | $4.16 | -53.05% | $4.61 | -2.95% | -50.10% |
| Sep 22, 2026 | $4.66 | -47.40% | $- | - | |
| Sep 21, 2026 | $4.66 | -47.40% | $4.68 | -1.47% | -45.93% |
| Sep 18, 2026 | $4.77 | -46.16% | $4.58 | -3.58% | -42.58% |
| Sep 17, 2026 | $4.89 | -44.81% | $4.60 | -3.16% | -41.65% |
| Sep 16, 2026 | $4.76 | -46.28% | $4.58 | -3.58% | -42.70% |
| Sep 15, 2026 | $4.88 | -44.92% | $4.74 | -0.21% | -44.71% |
Page 1 of 2